193 related articles for article (PubMed ID: 18669595)
1. A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism.
Neumann S; Kleinau G; Costanzi S; Moore S; Jiang JK; Raaka BM; Thomas CJ; Krause G; Gershengorn MC
Endocrinology; 2008 Dec; 149(12):5945-50. PubMed ID: 18669595
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes.
Jang D; Morgan SJ; Klubo-Gwiezdzinska J; Banga JP; Neumann S; Gershengorn MC
Thyroid; 2020 Feb; 30(2):270-276. PubMed ID: 31805824
[No Abstract] [Full Text] [Related]
3. Antithyroid drugs are 65 years old: time for retirement?
Beck-Peccoz P
Endocrinology; 2008 Dec; 149(12):5943-4. PubMed ID: 19022900
[No Abstract] [Full Text] [Related]
4. A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
Neumann S; Huang W; Eliseeva E; Titus S; Thomas CJ; Gershengorn MC
Endocrinology; 2010 Jul; 151(7):3454-9. PubMed ID: 20427476
[TBL] [Abstract][Full Text] [Related]
5. A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.
Neumann S; Eliseeva E; McCoy JG; Napolitano G; Giuliani C; Monaco F; Huang W; Gershengorn MC
J Clin Endocrinol Metab; 2011 Feb; 96(2):548-54. PubMed ID: 21123444
[TBL] [Abstract][Full Text] [Related]
6. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy.
Marcinkowski P; Hoyer I; Specker E; Furkert J; Rutz C; Neuenschwander M; Sobottka S; Sun H; Nazare M; Berchner-Pfannschmidt U; von Kries JP; Eckstein A; Schülein R; Krause G
Thyroid; 2019 Jan; 29(1):111-123. PubMed ID: 30351237
[TBL] [Abstract][Full Text] [Related]
7. A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.
Neumann S; Pope A; Geras-Raaka E; Raaka BM; Bahn RS; Gershengorn MC
Thyroid; 2012 Aug; 22(8):839-43. PubMed ID: 22784331
[TBL] [Abstract][Full Text] [Related]
8. Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action.
Ochi Y; Hachiya T; Koyama Y; Fukuhori N; Ashida N
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):508-512. PubMed ID: 29468987
[TBL] [Abstract][Full Text] [Related]
9. Update in TSH receptor agonists and antagonists.
Gershengorn MC; Neumann S
J Clin Endocrinol Metab; 2012 Dec; 97(12):4287-92. PubMed ID: 23019348
[TBL] [Abstract][Full Text] [Related]
10. Small molecule TSHR agonists and antagonists.
Neumann S; Gershengorn MC
Ann Endocrinol (Paris); 2011 Apr; 72(2):74-6. PubMed ID: 21511239
[TBL] [Abstract][Full Text] [Related]
11. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.
Zhang M; Tong KP; Fremont V; Chen J; Narayan P; Puett D; Weintraub BD; Szkudlinski MW
Endocrinology; 2000 Sep; 141(9):3514-7. PubMed ID: 10965926
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor.
van Koppen CJ; de Gooyer ME; Karstens WJ; Plate R; Conti PG; van Achterberg TA; van Amstel MG; Brands JH; Wat J; Berg RJ; Lane JR; Miltenburg AM; Timmers CM
Br J Pharmacol; 2012 Apr; 165(7):2314-24. PubMed ID: 22014107
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
14. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
Sanders J; Miguel RN; Furmaniak J; Smith BR
Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
[TBL] [Abstract][Full Text] [Related]
15. A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR).
Jäschke H; Neumann S; Moore S; Thomas CJ; Colson AO; Costanzi S; Kleinau G; Jiang JK; Paschke R; Raaka BM; Krause G; Gershengorn MC
J Biol Chem; 2006 Apr; 281(15):9841-4. PubMed ID: 16488885
[TBL] [Abstract][Full Text] [Related]
16. Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.
van Zeijl CJ; van Koppen CJ; Surovtseva OV; de Gooyer ME; Plate R; Conti P; Karstens WJ; Timmers M; Saeed P; Wiersinga WM; Miltenburg AM; Fliers E; Boelen A
J Clin Endocrinol Metab; 2012 May; 97(5):E781-5. PubMed ID: 22419705
[TBL] [Abstract][Full Text] [Related]
17. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
[TBL] [Abstract][Full Text] [Related]
18. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
19. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
Glinoer D; de Nayer P; Bex M;
Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
[TBL] [Abstract][Full Text] [Related]
20. A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice.
Neumann S; Nir EA; Eliseeva E; Huang W; Marugan J; Xiao J; Dulcey AE; Gershengorn MC
Endocrinology; 2014 Jan; 155(1):310-4. PubMed ID: 24169564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
